Reuters: Scandal-hit Chinese vaccine maker Changsheng started falsifying records in 2014: Xinhua
“Changsheng Bio-technology Co. Ltd., a vaccine maker at the center of a safety scandal in China, began falsifying production records for its rabies vaccine in April 2014, state news agency Xinhua reported on Tuesday. … China launched sweeping spot checks at vaccine makers around the country last month in a bid to rein in public outrage after Changsheng was found to have falsified data for the rabies vaccine and manufactured an ineffective vaccine for Chinese babies” (Goh, 8/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.